EGFR and neoplasm: Furthermore, several studies associate EGFR signaling with tumor progression of cancer, including breast, lung, head, and neck squamous cell carcinoma (HNSCC) and glioblastoma (Wada et al., 1990; Harari and Yarden, 2000; Blume-Jensen and Hunter, 2001).